Vergoeding 2019-2023 voor ATC-subgroep L01XL : Oncolytische cel- en gentherapie
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L01XL02 Talimogeen laherparepvec | 3.706.980 | 4.073.863 | 3.330.954 | 2.887.122 | 3.516.460 |
| L01XL03 Axicabtagen ciloleucel | . | 12.475.050 | 21.742.230 | 32.435.130 | 22.098.660 |
| L01XL04 Tisagenlecleucel | 4.185.600 | 4.185.600 | 2.441.600 | 2.790.400 | 2.441.600 |
| Totaal | 7.892.580 | 20.734.513 | 27.514.784 | 38.112.652 | 28.056.720 |